Bristol-Myers Squibb (BMY)
66.82
-1.27 (1.87%)
Upcoming Events
Latest Headlines
Form 4 BRISTOL MYERS SQUIBB CO For: Sep 01 Filed by: Short Bartie Wendy
September 3, 2026 4:12 PM - SEC Filing
BMS presents five-year Camzyos data for heart condition at ESC
August 31, 2026 6:05 AM - StreetInsider
Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European
August 29, 2026 11:00 AM - BizWire
Form 4 BRISTOL MYERS SQUIBB CO For: Aug 25 Filed by: Holzer Phil M
August 26, 2026 4:18 PM - SEC Filing
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
August 26, 2026 9:20 AM - StreetInsider
Form 144 BRISTOL MYERS SQUIBB CO Filed by: Holzer Phil M
August 25, 2026 11:04 AM - SEC Filing
UBS Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
August 20, 2026 10:02 AM - StreetInsider
Guggenheim Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
August 17, 2026 6:56 AM - StreetInsider
FDA grants accelerated approval to Bristol Myers Squibb's Zenbexus
August 13, 2026 5:12 PM - StreetInsider
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multip
August 13, 2026 5:12 PM - BizWire
Cytokinetics sues Bristol-Myers Squibb over aficamten patent dispute
August 13, 2026 9:26 AM - StreetInsider
Atrium Therapeutics receives $15M milestone from Bristol Myers Squibb
August 13, 2026 8:01 AM - StreetInsider
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
August 13, 2026 8:00 AM - PR NewsWire
Bristol Myers Squibb plans $2.3B manufacturing campus in Houston
August 10, 2026 9:02 AM - StreetInsider
Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas
August 10, 2026 9:01 AM - BizWire
Morgan Stanley tracks US drug market prescriptions for week ending July 31
August 7, 2026 12:04 PM - StreetInsider
Form SCHEDULE 13G BRISTOL MYERS SQUIBB CO Filed by: STATE STREET CORP
August 7, 2026 8:56 AM - SEC Filing
AZN spikes 6% after report it denies AstraZeneca-BMS merger talks
August 5, 2026 8:31 AM - StreetInsider
Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
August 5, 2026 8:14 AM - StreetInsider
'No Discussions' Over Astrazeneca-Bristol Myers Deal, Senior Source Says - Reuters
August 5, 2026 8:07 AM - StreetInsider
Argus Upgrades Bristol-Myers Squibb Co. (BMY) to Buy
August 5, 2026 7:55 AM - StreetInsider
Form 4 BRISTOL MYERS SQUIBB CO For: Aug 01 Filed by: Massacesi Cristian
August 4, 2026 4:11 PM - SEC Filing
Form 4 BRISTOL MYERS SQUIBB CO For: Aug 01 Filed by: Gallman Cari
August 4, 2026 4:08 PM - SEC Filing
RBC Capital on Bristol-Myers Squibb's (BMY) AZN Deal Feedback
August 4, 2026 8:48 AM - StreetInsider
Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?
August 3, 2026 11:24 AM - StreetInsider
AstraZeneca reviews potential Bristol Myers deal, Barclays comments
August 3, 2026 8:17 AM - StreetInsider
Bristol-Myers Squibb (BMY) call put ratio 1 call to 1.5 puts into share price up before the bell
August 3, 2026 5:51 AM - StreetInsider
Stocks expected to have increasing option volume: BMY AZN MRK GILD MRNA PFE AMGN PLTR MAR AMD CAT MRK MCD REPL
August 3, 2026 5:44 AM - StreetInsider
U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
August 1, 2026 10:00 AM - StreetInsider
Bristol-Myers Squibb Co. (BMY) PT Raised to $55 at Cantor Fitzgerald
July 31, 2026 10:22 AM - StreetInsider
Bristol-Myers Squibb Co. (BMY) PT Raised to $73 at JPMorgan
July 31, 2026 8:56 AM - StreetInsider
Bristol-Myers Squibb Co. (BMY) PT Raised to $65 at Wells Fargo
July 31, 2026 8:35 AM - StreetInsider
Bristol-Myers Squibb Co. (BMY) PT Raised to $64 at RBC Capital
July 31, 2026 8:14 AM - StreetInsider
Bristol-Myers Squibb Co. (BMY) PT Raised to $70 at Truist Securities
July 31, 2026 7:09 AM - StreetInsider
Bristol-Myers Squibb Co. (BMY) PT Raised to $75 at Guggenheim
July 31, 2026 6:59 AM - StreetInsider
Form 10-Q BRISTOL MYERS SQUIBB CO For: Jun 30
July 30, 2026 11:11 AM - SEC Filing
Bristol-Myers Squibb raises annual outlook as Q2 tops estimates; shares up
July 30, 2026 7:25 AM - StreetInsider
Form 8-K BRISTOL MYERS SQUIBB CO For: Jul 30
July 30, 2026 7:06 AM - SEC Filing
Bristol-Myers Squibb (BMY) Tops Q2 EPS by 43c, Beats on Revenue; Offers FY26 Guidance
July 30, 2026 7:00 AM - StreetInsider
Bristol Myers Squibb Reports Second Quarter Financial Results for 2026
July 30, 2026 6:59 AM - BizWire
Bristol-Myers Squibb (BMY) call put ratio 1 call to 1 put into quarter results
July 29, 2026 11:31 AM - StreetInsider
Raymond James on Bristol-Myers Squibb Co. (BMY): 'we do not view the ZEPHYR data as signaling a risk to Cobenfy across indications'
July 27, 2026 2:29 PM - StreetInsider
BMO Capital Reiterates Market Perform Rating on Bristol-Myers Squibb Co. (BMY)
July 27, 2026 8:23 AM - StreetInsider
Bristol Myers buys Nvidia's latest AI computing system for drug research
July 20, 2026 7:01 AM - StreetInsider
Bristol Myers Squibb expands Nvidia AI infrastructure for drug discovery
July 20, 2026 6:59 AM - StreetInsider
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
July 20, 2026 6:59 AM - BizWire
FDA accepts Bristol Myers Squibb's mezigdomide application for myeloma
July 13, 2026 6:59 AM - StreetInsider
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
July 13, 2026 6:59 AM - BizWire
Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: YALE PHYLLIS R
July 2, 2026 4:20 PM - SEC Filing
Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: Samuels Theodore R. II
July 2, 2026 4:18 PM - SEC Filing
Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: Rice Derica W
July 2, 2026 4:18 PM - SEC Filing
Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: McMullen Michael R.
July 2, 2026 4:17 PM - SEC Filing
Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: Arduini Peter J
July 2, 2026 4:16 PM - SEC Filing
The Quest to Repair What Multiple Sclerosis Takes Away
June 24, 2026 8:30 AM - StreetInsider
Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026
June 18, 2026 6:59 AM - BizWire
Bristol-Myers Squibb (BMY) Declares $0.63 Quarterly Dividend; 4.6% Yield
June 17, 2026 4:16 PM - StreetInsider
Bristol Myers Squibb Announces Dividend
June 17, 2026 4:16 PM - BizWire
Form 4 BRISTOL MYERS SQUIBB CO For: Jun 15 Filed by: Haller Julia A
June 16, 2026 4:08 PM - SEC Filing
Leerink highlights drug demand rebound after Memorial Day
June 12, 2026 2:42 PM - StreetInsider
Bristol-Myers Squibb (BMY) call put ratio 6.8 calls to 1 put with a focus on spreader of 8244 contracts of June and July 57.50 calls
June 11, 2026 2:50 PM - StreetInsider
Mariska Hargitay partners with Bristol Myers Squibb for myeloma awareness
June 8, 2026 7:00 AM - StreetInsider
Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease
June 8, 2026 6:59 AM - BizWire
Full Article List
